Traverse harnesses clinically validated technologies to make the immune system part of the cure. We are developing the next generation of first-in-class immunotherapies. Each pipeline product that Traverse acquires is based on a clinically validated platform in an original risk-sharing model with the licensing partner thereby leveraging technical and developmental expertise. Our lead product is a T-cell engaging bispecific antibody that overcomes the immunosuppressive tumor microenvironment in difficult-to-treat solid cancers.
Company Details
- Employees
- 7
- Address
- 708 Greenwich St, New York,10014,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.traversebiotech.com
- Keywords
- New York.
- HQ
- New York
Traverse Biotech, Inc Questions
Traverse Biotech, Inc's website is http://www.traversebiotech.com
Traverse Biotech, Inc's LinkedIn profile is https://www.linkedin.com/company/traversebiotech
Traverse Biotech, Inc has
7 employees.
View email and phone details for 7
employees at Traverse Biotech, Inc.
Traverse Biotech, Inc's industry is
Biotechnology Research
Traverse Biotech, Inc's top competitors are
Aclys Bio,
Celdara Medical,
Traverse Consulting,
Azure Biotech Inc.,
Pfizer,
Avitide, Llc, A Repligen Company,
Accutar Biotech,
Sylentia Biotech,
Onethree Biotech,
Immunext.
Traverse Biotech, Inc's categories are Biotechnology Research
